The daily business briefing: December 1, 2020

The Dow falls but still posts its best month since 1987, Moderna applies for coronavirus vaccine emergency-use authorization, and more

The Moderna hq
(Image credit: Maddie Meyer/Getty Images)

1. U.S. stocks fall on final day of blockbuster month

U.S. stock indexes fell on Monday but still finished November with massive gains. The Dow Jones Industrial Average dropped by 0.9 percent on Monday, but still gained 12 percent in November, its best month since January 1987. The S&P 500 fell by 0.5 percent to finish the month up by 11 percent. The Nasdaq finished the month up 12 percent. Futures for the Dow and the S&P 500 were up 1 percent several hours before the opening bell on Tuesday, buoyed by positive news on coronavirus vaccine development. Federal Reserve Chair Jerome Powell warned the outlook for the economy remained "extraordinarily uncertain," and a full recovery "is unlikely until people are confident that it is safe to reengage in a broad range of activities."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.